
Galapagos NV GLPG
€ 24.49
-0.91%
Geschäftsbericht 2025
hinzugefügt 04.04.2026
Galapagos NV P/E 2011-2026 | GLPG
P/E Jährlich Galapagos NV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -42.8 | -22.2 | 0.0856 | -183 | -50.6 | 951 | -12.5 | 15.8 | -73.8 | -97.1 | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 951 | -183 | 48.5 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.85 | 3.22 % | $ 9.26 B | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
130 | $ 330.55 | -0.85 % | $ 43.3 B | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-2.73 | $ 7.51 | 1.21 % | $ 74.2 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.544 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 21.68 | - | $ 1.01 B | ||
|
CymaBay Therapeutics
CBAY
|
-32.5 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
6.11 | $ 99.49 | 0.02 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Burford Capital Limited
BUR
|
12.2 | $ 4.79 | 1.06 % | $ 771 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Cabaletta Bio
CABA
|
-1.69 | $ 3.46 | 1.62 % | $ 348 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 3.17 | -2.16 % | $ 5.22 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-0.0166 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-62.5 | $ 1.5 | -3.23 % | $ 386 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-5.58 | $ 4.24 | -0.12 % | $ 453 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 24.54 | -0.18 % | $ 3.12 B | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.48 | -1.01 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-2.85 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.179 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-3.12 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
-7.88 | $ 33.97 | 0.3 % | $ 2.26 B | ||
|
bluebird bio
BLUE
|
-0.316 | - | - | $ 546 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.0669 | $ 2.67 | -2.91 % | $ 1.18 M | ||
|
AstraZeneca PLC
AZN
|
706 | - | - | $ 96.9 B |